ClinVar Miner

Submissions for variant NM_000152.5(GAA):c.1346C>T (p.Ser449Leu)

dbSNP: rs753483808
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen Lysosomal Storage Disorder Variant Curation Expert Panel RCV000886768 SCV005089703 uncertain significance Glycogen storage disease, type II 2024-04-02 reviewed by expert panel curation The NM_000152.5:c.1346C>T variant in GAA is a missense variant predicted to cause substitution of serine with leucine at amino acid 449 (p.Ser449Leu). The highest population minor allele frequency in gnomAD v2.1.1. is 0.001177 (36/30594 alleles), including 2 homozygotes, in the South Asian population, which is lower than the ClinGen Lysosomal Diseases VCEP’s threshold for PM2_Supporting (<0.001), meeting this criterion. Three patient(s) with this variant had documented GAA deficiency with activity in the affected range in muscle, cultured skin fibroblasts, leukocytes, lymphocytes, whole blood or dried blood spot (PMIDs 33202836, 33301762). However, due to the frequency of homozygotes in gnomAD, PP4 was not applied. The computational predictor REVEL gives a score of 0.307 which is below the threshold of 0.5, evidence that does not predict a damaging effect on GAA function (BP4). There is a ClinVar entry for this variant (Variation ID: 714463, 1-star review status) with one submitter classifying as likely benign and one classifying as a variant of uncertain significance. In summary, this variant meets the criteria to be classified as a variant of uncertain significance for Pompe disease based on the ACMG/AMP criteria applied, as specified by the ClinGen Lysosomal Diseases Variant Curation Expert Panel (specifications Version 2.0): PM2_Supporting, BP4. (Classification approved by the ClinGen Lysosomal Diseases Variant Curation Expert Panel on April 2, 2024).
Labcorp Genetics (formerly Invitae), Labcorp RCV000886768 SCV001030295 likely benign Glycogen storage disease, type II 2025-01-23 criteria provided, single submitter clinical testing
Revvity Omics, Revvity RCV003130083 SCV003810585 uncertain significance not provided 2023-08-16 criteria provided, single submitter clinical testing
Mayo Clinic Laboratories, Mayo Clinic RCV003130083 SCV005408537 uncertain significance not provided 2024-05-31 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.